Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

The New England Journal of Medicine
R BadaróL Silva

Abstract

Acute visceral leishmaniasis is associated with an antigen-specific immunosuppression of mononuclear cells as evidenced by defective in vitro production of interferon gamma. We evaluated treatment with recombinant human interferon gamma in combination with conventional pentavalent antimony therapy in patients with visceral leishmaniasis. Six of eight patients with visceral leishmaniasis (mean duration, 17 months) that had been unresponsive to multiple courses of pentavalent antimony responded to treatment with recombinant human interferon gamma (100 to 400 micrograms per square meter of body-surface area per day) in addition to pentavalent antimony (20 mg per kilogram of body weight per day) for 10 to 40 days. The other two patients improved initially but then relapsed and required treatment with amphotericin B. Eight of nine additional patients with previously untreated severe visceral leishmaniasis were also successfully treated with the combination of interferon gamma and pentavalent antimony. The 14 patients who responded to this regimen had marked improvement in symptoms and in measures of anemia and leukopenia, as well as weight gain, a decrease in spleen size, and an absence or reduction of leishmanias in splenic aspirat...Continue Reading

References

Mar 1, 1989·The Journal of Clinical Investigation·E M CarvalhoW D Johnson
Jan 1, 1985·Annual Review of Immunology·S K DurumJ J Oppenheim
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·N E ReinerW R McMaster
Jan 1, 1985·Transactions of the Royal Society of Tropical Medicine and Hygiene·A D BrycesonH C Spencer
Dec 1, 1986·The Journal of Infectious Diseases·R BadaroW D Johnson
Aug 1, 1985·The Journal of Infectious Diseases·G D CrawfordC A Dinarello
Dec 1, 1985·The Journal of Clinical Investigation·E M CarvalhoW D Johnson
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C F NathanS E Krown
Oct 1, 1984·The Journal of Experimental Medicine·G TrinchieriB Perussia
Jan 1, 1982·Immunological Reviews·S B Mizel
Dec 1, 1982·The Journal of Experimental Medicine·P S SteegJ J Oppenheim
May 1, 1983·The American Journal of Tropical Medicine and Hygiene·J D Chulay, A D Bryceson

❮ Previous
Next ❯

Citations

Jan 1, 1993·Transplant International : Official Journal of the European Society for Organ Transplantation·F F HorberR Malinverni
Dec 1, 1994·The American Journal of Gastroenterology·O LinI J Lustbader
Jan 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R BadaróT C Jones
Mar 1, 1991·Transactions of the Royal Society of Tropical Medicine and Hygiene·M Hommel
Jan 1, 1991·Transactions of the Royal Society of Tropical Medicine and Hygiene·M U IwobiR A Neal
Mar 1, 1993·Transactions of the Royal Society of Tropical Medicine and Hygiene·R N Davidson, S L Croft
May 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·S TeklemariamA Bryceson
May 1, 1993·Trends in Pharmacological Sciences·F Powrie, R L Coffman
Jun 1, 1992·Immunology Today·M Howard, A O'Garra
Jun 1, 1993·Immunology Today·F Powrie, R L Coffman
Jan 1, 1991·Parasitology Today·M J DoenhoffD J McLaren
Jan 1, 1993·Parasitology Today·P L Olliaro, A D Bryceson
Jan 1, 1994·Parasitology Today·J Alvar
Sep 1, 1995·Research in Immunology·D J FowellR M Locksley
Apr 1, 1996·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·R PiarrouxD Unal
Feb 1, 1991·Current Opinion in Immunology·M C Dinauer, R A Ezekowitz
Oct 1, 1991·Current Opinion in Immunology·H F Oettgen
Aug 1, 1993·Current Opinion in Immunology·S G Reed, P Scott
Jan 2, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·M BoelaertP Van der Stuyft
May 1, 1996·Transactions of the Royal Society of Tropical Medicine and Hygiene·C P ThakurP Olliaro
Aug 15, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·B PapadopoulouM Ouellette
Feb 21, 1991·The New England Journal of Medicine·UNKNOWN International Chronic Granulomatous Disease Cooperative Study Group
Mar 31, 1991·The New England Journal of Medicine·R A GasserE C Tramont
May 28, 1992·The New England Journal of Medicine·E C Borden
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H C MaltezouD A Kafetzis
Apr 30, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·A-K LichtE Faist
Sep 27, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Christian Schinkel
Nov 5, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·V BhakuniR K Maheshwari
Sep 27, 2005·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Ernest C Borden
Feb 1, 1994·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M KempT G Theander
Feb 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J BahrenscheerT G Theander

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.